Abstract
Insulin secretion from pancreatic β-cells is tightly regulated to keep fasting blood glucose concentrations within the normal range (3.5-5.5 mmol/L). Hyperinsulinaemic hypoglycaemia (HH) is a heterozygous condition in which insulin secretion becomes unregulated and its production persists despite low blood glucose levels. It is the most common cause of severe and persistent hypoglycaemia in neonates and children. The most severe and permanent forms are due to congenital hyperinsulinism (CHI). Recent advances in genetics have linked CHI to mutations in 9 genes that play a key role in regulating insulin secretion (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, UCP2, HNF4A and HNF1A). Histologically, CHI can be divided into 3 types; diffuse, focal and atypical. Given the biochemical nature of HH (non-ketotic), a delay in the diagnosis and management can result in irreversible brain damage. Therefore, it is essential to diagnose and treat HH promptly. Advances in molecular genetics, imaging methods (18F-DOPA PET-CT), medical therapy and surgical approach (laparoscopic surgery) have completely changed the management and improved the outcome of these children. This review provides an overview of the genetic and molecular mechanisms leadin...Continue Reading
Citations
Nov 26, 2015·European Journal of Medical Genetics·Alessandro MussaGiovanni Battista Ferrero
Oct 12, 2016·PloS One·Mihaela FriciuGrégoire Leclair
Mar 21, 2017·Pediatric Diabetes·S E FlanaganS Ellard
Nov 12, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Klara RozenkovaStepanka Pruhova
Feb 13, 2019·Endocrinology, Diabetes & Metabolism Case Reports·Sarah KiffPratik Shah
Apr 20, 2019·Fetal and Pediatric Pathology·Yiting DuPeng Gou
Jan 30, 2018·Nature Reviews. Endocrinology·Frédéric BrioudeEamonn R Maher
Mar 22, 2018·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Amish ChinoyStefania Bitetti
Jul 22, 2018·Orphanet Journal of Rare Diseases·Sana EljamelRichard Thompson
Oct 28, 2017·British Journal of Clinical Pharmacology·Chee M NgDiva D De León
Feb 1, 2020·European Journal of Pediatrics·K El TonbaryM G Shaikh
Jul 21, 2016·Molecular Pharmacology·Myrian VelascoMarcia Hiriart
Dec 24, 2018·Orphanet Journal of Rare Diseases·Alena WeltersReinhard W Holl
Mar 19, 2020·Reviews in Endocrine & Metabolic Disorders·Maria GϋemesPratik Shah
Jul 12, 2017·BMC Nephrology·Stephen Benedict WalshDetlef Bockenhauer
Apr 28, 2020·Channels·María Carmen De Mingo AlemanySara León Cariñena
Sep 16, 2020·Italian Journal of Pediatrics·Alberto CasertanoAdriana Franzese
Sep 13, 2018·Journal of Perinatology : Official Journal of the California Perinatal Association·Keyaria D GrayUNKNOWN Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee
Nov 3, 2020·Frontiers in Endocrinology·Zhen-Ran XuMiao-Ying Zhang
Nov 12, 2020·Archives of Disease in Childhood. Fetal and Neonatal Edition·Laura A PradoJaques Belik
Dec 22, 2020·Clinical Endocrinology·Eirini KostopoulouPratik Shah
Mar 27, 2021·European Journal of Pediatrics·Maja RaicevicRade Vukovic
Sep 3, 2020·Annals of Pediatric Endocrinology & Metabolism·Julie Mouron-HryciukMichael Hauschild
Apr 3, 2021·NeoReviews·Kathryn Sims
Jan 24, 2021·Pediatrics·Madeline L KeyesJuan D Matute